173 related articles for article (PubMed ID: 30120376)
1. miR-22 suppresses DNA ligase III addiction in multiple myeloma.
Caracciolo D; Di Martino MT; Amodio N; Morelli E; Montesano M; Botta C; Scionti F; Talarico D; Altomare E; Gallo Cantafio ME; Zuccalà V; Maltese L; Todoerti K; Rossi M; Arbitrio M; Neri A; Tagliaferri P; Tassone P
Leukemia; 2019 Feb; 33(2):487-498. PubMed ID: 30120376
[TBL] [Abstract][Full Text] [Related]
2. Rac GTPase activating protein 1 promotes gallbladder cancer via binding DNA ligase 3 to reduce apoptosis.
Bian R; Dang W; Song X; Liu L; Jiang C; Yang Y; Li Y; Li L; Li X; Hu Y; Bao R; Liu Y
Int J Biol Sci; 2021; 17(9):2167-2180. PubMed ID: 34239347
[TBL] [Abstract][Full Text] [Related]
3. Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin.
Caracciolo D; Juli G; Riillo C; Coricello A; Vasile F; Pollastri S; Rocca R; Scionti F; Polerà N; Grillone K; Arbitrio M; Staropoli N; Caparello B; Britti D; Loprete G; Costa G; Di Martino MT; Alcaro S; Tagliaferri P; Tassone P
J Transl Med; 2022 Oct; 20(1):482. PubMed ID: 36273153
[TBL] [Abstract][Full Text] [Related]
4. Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.
Hu Y; Lin J; Fang H; Fang J; Li C; Chen W; Liu S; Ondrejka S; Gong Z; Reu F; Maciejewski J; Yi Q; Zhao JJ
Leukemia; 2018 Oct; 32(10):2250-2262. PubMed ID: 29632340
[TBL] [Abstract][Full Text] [Related]
5. miR-125a suppresses malignancy of multiple myeloma by reducing the deubiquitinase USP5.
Wu L; Zhang C; Chu M; Fan Y; Wei L; Li Z; Yao Y; Zhuang W
J Cell Biochem; 2020 Jan; 121(1):642-650. PubMed ID: 31452281
[TBL] [Abstract][Full Text] [Related]
6. Biallelic variants in LIG3 cause a novel mitochondrial neurogastrointestinal encephalomyopathy.
Bonora E; Chakrabarty S; Kellaris G; Tsutsumi M; Bianco F; Bergamini C; Ullah F; Isidori F; Liparulo I; Diquigiovanni C; Masin L; Rizzardi N; Cratere MG; Boschetti E; Papa V; Maresca A; Cenacchi G; Casadio R; Martelli P; Matera I; Ceccherini I; Fato R; Raiola G; Arrigo S; Signa S; Sementa AR; Severino M; Striano P; Fiorillo C; Goto T; Uchino S; Oyazato Y; Nakamura H; Mishra SK; Yeh YS; Kato T; Nozu K; Tanboon J; Morioka I; Nishino I; Toda T; Goto YI; Ohtake A; Kosaki K; Yamaguchi Y; Nonaka I; Iijima K; Mimaki M; Kurahashi H; Raams A; MacInnes A; Alders M; Engelen M; Linthorst G; de Koning T; den Dunnen W; Dijkstra G; van Spaendonck K; van Gent DC; Aronica EM; Picco P; Carelli V; Seri M; Katsanis N; Duijkers FAM; Taniguchi-Ikeda M; De Giorgio R
Brain; 2021 Jun; 144(5):1451-1466. PubMed ID: 33855352
[TBL] [Abstract][Full Text] [Related]
7. Ligase 3-mediated end-joining maintains genome stability of human embryonic stem cells.
Kohutova A; Raška J; Kruta M; Seneklova M; Barta T; Fojtik P; Jurakova T; Walter CA; Hampl A; Dvorak P; Rotrekl V
FASEB J; 2019 Jun; 33(6):6778-6788. PubMed ID: 30807703
[TBL] [Abstract][Full Text] [Related]
8. Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair.
Simsek D; Furda A; Gao Y; Artus J; Brunet E; Hadjantonakis AK; Van Houten B; Shuman S; McKinnon PJ; Jasin M
Nature; 2011 Mar; 471(7337):245-8. PubMed ID: 21390132
[TBL] [Abstract][Full Text] [Related]
9. DNA ligase III is critical for mtDNA integrity but not Xrcc1-mediated nuclear DNA repair.
Gao Y; Katyal S; Lee Y; Zhao J; Rehg JE; Russell HR; McKinnon PJ
Nature; 2011 Mar; 471(7337):240-4. PubMed ID: 21390131
[TBL] [Abstract][Full Text] [Related]
10. Human DNA ligases in replication and repair.
Sallmyr A; Rashid I; Bhandari SK; Naila T; Tomkinson AE
DNA Repair (Amst); 2020 Sep; 93():102908. PubMed ID: 33087274
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of LncRNA ANRIL mediated by miR-411-3p inhibits the malignant proliferation and tumor stem cell like property of multiple myeloma via hypoxia-inducible factor 1α.
Wang M; Zhao HY; Zhang JL; Wan DM; Li YM; Jiang ZX
Exp Cell Res; 2020 Nov; 396(1):112280. PubMed ID: 32961145
[TBL] [Abstract][Full Text] [Related]
12. DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation.
Simsek D; Brunet E; Wong SY; Katyal S; Gao Y; McKinnon PJ; Lou J; Zhang L; Li J; Rebar EJ; Gregory PD; Holmes MC; Jasin M
PLoS Genet; 2011 Jun; 7(6):e1002080. PubMed ID: 21655080
[TBL] [Abstract][Full Text] [Related]
13. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.
Liu S; Zhang Y; Huang C; Lin S
J Cell Biochem; 2020 Feb; 121(2):1475-1490. PubMed ID: 31498483
[TBL] [Abstract][Full Text] [Related]
14. Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth.
Leone E; Morelli E; Di Martino MT; Amodio N; Foresta U; Gullà A; Rossi M; Neri A; Giordano A; Munshi NC; Anderson KC; Tagliaferri P; Tassone P
Clin Cancer Res; 2013 Apr; 19(8):2096-106. PubMed ID: 23446999
[TBL] [Abstract][Full Text] [Related]
15. miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma.
Rossi M; Altomare E; Botta C; Gallo Cantafio ME; Sarvide S; Caracciolo D; Riillo C; Gaspari M; Taverna D; Conforti F; Critelli P; Bertucci B; Iannone M; Polerà N; Scumaci D; Arbitrio M; Amodio N; Di Martino MT; Paiva B; Tagliaferri P; Tassone P
Leukemia; 2021 Mar; 35(3):823-834. PubMed ID: 32632096
[TBL] [Abstract][Full Text] [Related]
16.
Roth BM; Varney KM; Yang H; Weber DJ; Tomkinson AE
Biomol NMR Assign; 2019 Oct; 13(2):305-308. PubMed ID: 31093909
[TBL] [Abstract][Full Text] [Related]
17. THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair Inhibitors.
Shyamsunder P; Sridharan SP; Madan V; Dakle P; Zeya C; Kanojia D; Chng WJ; Ong ST; Koeffler HP
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163134
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA ligase is dispensable for the viability of cultured cells but essential for mtDNA maintenance.
Shokolenko IN; Fayzulin RZ; Katyal S; McKinnon PJ; Wilson GL; Alexeyev MF
J Biol Chem; 2013 Sep; 288(37):26594-605. PubMed ID: 23884459
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis.
Wang H; Chen W; Yang P; Zhou J; Wang K; Tao Q
Cancer Biol Ther; 2019; 20(4):461-473. PubMed ID: 30404587
[TBL] [Abstract][Full Text] [Related]
20. Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression.
De Smedt E; Maes K; Verhulst S; Lui H; Kassambara A; Maes A; Robert N; Heirman C; Cakana A; Hose D; Breckpot K; van Grunsven LA; De Veirman K; Menu E; Vanderkerken K; Moreaux J; De Bruyne E
Cancer Res; 2018 Mar; 78(5):1155-1168. PubMed ID: 29259009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
